Not too much action today, Dianthus Therapeutics drifted down slightly. We'll see where it goes next.
Currently DNTH isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! Dianthus Therapeutics has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 137.04 percent which isn't too bad. DNTH may hit some resistance around the 83.59 level, more sellers may enter the market here and push price back down. But it's definitely not guaranteed.
